The aim of the study was to investigate the occurrence of fatigue in 100 pediatric liver transplant recipients aged 2-18 years and its impact on their health-related quality of life (HRQL). HRQL and fatigue were measured using the PedsQL 4.0 Inventory and the PedsQL Multidimensional Fatigue Scale, which encompasses three subscales: general fatigue, sleep/rest fatigue, and cognitive fatigue. The impact of the different domains of fatigue and of clinical and sociodemographic factors on the HRQL was identified with stepwise multiple regression analyses. Parent proxy-reports were available for all 100 participants (2-18 years), and child self-reports were available for 71 patients (8-18 years). Across all domains, participants and their parents reported significantly more fatigue than healthy peers in a large PedsQL validation study.
| INTRODUC TI ON
LT is a life-saving intervention for children with end-stage liver disease. Medical outcomes have improved in recent years, with excellent results in graft and patient survival. In experienced centers, long-term patient survival currently exceeds 90%. 1 However, when considering all aspects of health, it is necessary to look beyond survival and graft function and focus on overall well-being and functional outcomes for PLT recipients. Recent reviews suggest that HRQL outcomes for PLT recipients are significantly lower than for healthy peers. [2] [3] [4] According to the literature, fatigue is one aspect that is frequently reported to have a large impact on the HRQL of patients with chronic conditions. [5] [6] [7] Fatigue is characterized by a persistent, subjective experience of weakness, lack of energy, and a sense of physical, emotional, and/or cognitive tiredness or exhaustion. It is not proportional to recent activities, and it interferes with normal function. 7, 8 Since fatigue is a rather unspecific phenomenon based on subjective perceptions, it is quite difficult to achieve a common understanding. Moreover, the underlying mechanisms of fatigue are poorly understood. 8 The reported prevalence of fatigue therefore varies widely. In the general population, prevalence rates from different studies range from 4.3% to 15%. [9] [10] [11] [12] In cancer patients, rates of 4% to 91% have been reported, depending on the population studied and the methods of assessment. 13 Although fatigue is one of the most prevalent symptoms in children with chronic conditions, [5] [6] [7] 14, 15 very little attention has been paid to fatigue in PLT recipients. However, fatigue occurs in up to two-thirds of adult patients with chronic cholestatic liver disease and biliary cirrhosis 16 and persists even after LT. [17] [18] [19] [20] Considering that sleep quality is a known predictor of fatigue 5 and sleep problems may contribute to fatigue, 21 the results of three studies on sleep problems after PLT [21] [22] [23] indicate that fatigue frequently occurs in PLT recipients. Furthermore, a recent review reported lower HRQL scores in PLT recipients with sleep disturbances. 4 The aim of this study was to investigate the occurrence of fatigue in PLT recipients and its impact on their HRQL. We hypothesized that participants in the study would experience significantly more fatigue than healthy peers. We also expected a high impact of fatigue on participants' HRQL. By exploratory analysis, we investigated the relation between fatigue and immunosuppressive therapy.
| PATIENTS AND ME THODS

| PLT sample
The investigation is part of our psychosocial diagnostic routine during the patients' regular follow-up visits at our Transplant Center of the University Medical Center Hamburg, Germany. PLT recipients were eligible if (a) they were between 2 and 18 years of age, (b) they received PLT at least 12 months prior to participation, and (c) patients and parents were fluent in German. The ethics committee of the State Chamber of Physicians in Hamburg, Germany, approved the study. Informed consent was obtained from parents and from patients between 8 and 18 years of age. All medical information was collected from the patients' charts.
| Healthy samples
The current data are results of our psychosocial diagnostic routine.
Hence, no control group can be provided. 
| Statistical analysis
Patient characteristics and demographic variables were described as mean values, standard deviations and ranges, or percentages. Group differences were analyzed using independent t tests. To identify patients with a clinically relevant measure of fatigue or impaired HRQL, we dichotomized each scale.
For the PedsQL total score, we used cutoff points suggested by the authors of the PedsQL. 24 They determined one standard deviation below the mean of a large healthy pediatric population as an at-risk status for impaired HRQL, and we therefore defined this as "poor." For PedsQL MFS, we used the same approach. We determined fatigue as present at a "clinically relevant 
| RE SULTS
| Description of the PLT sample
During the study period, 107 patients were eligible for participation. Four parents declined participation, and three participations were canceled for logistic reasons. The total sample included 100 patients (94%). Parent proxy-reports were available for all 100 enrolled participants. Both child self-reports and the parent proxyreports were available for 71 patients from 8 to 18 years of age.
The demographic and clinical characteristics of participants are presented in Table 1 . Table 2 shows the PedsQL MFS scores and the PedsQL scores of PLT recipients and healthy peers, together with effect sizes. For all domains of fatigue, PLT recipients and their parents reported scores significantly lower than healthy subjects, indicating higher levels of fatigue in patients after PLT. All differences in the parent proxy-report had large effect sizes (P < 0.001, d = 0.87-1.21). The largest effect was found for total fatigue. Effect sizes for the child self-report ranged from small to medium (d = 0.34-0.73), with the greatest effect for sleep/rest fatigue. This domain is also the one most impaired for both the child self-report and the parent proxy-report.
| Fatigue in PLT recipients compared with healthy peers
TA B L E 2 Scale descriptives for PedsQL™ Multidimensional Fatigue Scale and PedsQL™ 4.0 Generic Core Scales: child self-report and parent proxy-report and comparisons with healthy children scores Figure 1 shows that 37% of children and 57% of parents reported clinically relevant or even severe levels of total fatigue. Regarding the different domains of fatigue, the highest prevalence of fatigue was found in the sleep/rest fatigue subscale. In this domain, nearly half the patients (45%) and 56% of parents' reports had ratings of at least one standard deviation below the mean of healthy peers.
| Prevalence of fatigue in the PLT sample
Severe fatigue was recorded in 17% of child self-reports and 37% of parent proxy-reports.
| Fatigue and immunosuppressive therapy
There were no significant group differences in any of the fatigue domains of the PedsQL MFS (P = 0.78-0.99) with regard to type of immunosuppression, monotherapy vs more than one immunosuppressive medication, or corticosteroids vs no corticosteroids.
| HRQL in PLT sample
Compared to healthy peers, the PedsQL total scores of PLT recipi- Table 3 shows the strong relationship between fatigue and the PedsQL scales. The correlations between the domains of HRQL and the different fatigue scales were all significant (P < 0.01 resp. P < 0.001). For child self-report and parent proxy-report, the highest correlations were found between total fatigue and the PedsQL total score (r = 0.786 resp. r = 0.754). Regarding the subscales child self-reported and parent proxy-reported cognitive fatigue was highly correlated with social functioning (r = 0.693 resp. Table 4 .
| Relationship between fatigue and HRQL
Neither sleep/rest fatigue was a significant predictor of the PedsQL total score, nor were gender, marital status of parents, age at PLT, time since PLT, diagnosis, kind of donor, or type of immunosuppressive therapy.
| D ISCUSS I ON
To our knowledge, this is the first study to examine fatigue in PLT recipients using a multidimensional instrument and to investigate the contribution of fatigue to child's HRQL. As hypothesized, PLT recipients of our sample showed significantly higher levels of fatigue than healthy peers in all domains.
| Prevalence of fatigue in PLT recipients
Findings of a German study on fatigue in the general population (14-92 years) 28 suggest that fatigue increases with age. Therefore, rates of our sample (25%-57% in different domains) are extremely high compared to 6.1% in an adult sample of the German population. 12 The most impaired domain was sleep/rest fatigue for both child self-report and parent proxy-report. A high number of PLT recipients obviously suffer from tiredness and sleep difficulties. This is confirmed by previous research on sleep quality and sleep disturbances in PLT recipients, which were common in the study samples. [21] [22] [23] However, fatigue should not be directly attributed to sleep disturbances since fatigue is not necessarily improved by sleep, as studies on patients with chronic conditions like cancer suggest. 29, 30 There is some evidence that PLT recipients have similar experiences. Taylor et al 31 cited a PLT recipient who described fatigue as a "lack of energy. It's not like the kind of tiredness that will help you go to sleep, but just really not feeling particularly lively." (p. 1082). The authors suggest that although increasing the amount of sleep might be ineffective, it still appeared to be a common strategy of PLT recipients to cope with tiredness.
| Fatigue and immunosuppression
Regarding the immunosuppressive therapy, we found no significant differences in the PedsQL MFS scales. These results are consistent with those observed in a study on adult liver transplant recipients. 
| Fatigue and HRQL
As expected, fatigue had a high impact on participants' HRQL.
However, only cognitive fatigue and general fatigue were significant predictors of both child self-report and parent proxy-report and explained high percentages of variance in the PedsQL total score. Cognitive functioning in childhood is a prerequisite for successful school achievement and highly predictive for educational achievement and later occupational outcome. 33 Therefore, impairments due to cognitive fatigue might have several implications, especially for school performance. This is confirmed by the high correlations between cognitive fatigue and school functioning which was the most impaired domain of child's HRQL in our sample. In the parents' ratings, further predictors were child's age and family income. Due to their immature immune system, infants and toddlers in general are more susceptible to infections 35 and even more under immunosuppressive therapy. Therefore, it is not surprising that younger age was related to poorer HRQL. It is also well known that family income has an impact on child's HRQL. For example, compared to other socioeconomic status indicators, family income had the greatest impact on HRQL in a large study on children and adolescents with heart disease. 36 The discrepancies between the first two regression models can be explained by the different age ranges (child self-report: 8-18 years vs parent proxy-report:
2-18 years) as shown by the third regression analyses (parent proxyreport: 8-18 years). Shemesh et al 37 suggest that parent proxy-reports of child's symptoms are partly dependent on the parents' own emotions. Therefore, they might underestimate or overestimate the symptoms of their children. Due to the closer relationship between parents and very young children, the ratings of these parents might be even more affected by their own experiences and emotions than the ratings of parents with older children. 35 Furthermore, for most parents, family income might increase with the child's age. Working mothers often stay at home to care for the child following transplant. 38 However, the lacking possibility to return to work after LT is more likely for mothers of infants and toddlers due to the higher burden of caregiving responsibilities and tasks. 35 Unexpectedly, sleep/rest fatigue did not significantly predict the PedsQL total score, although it was the most impaired domain. It is important to consider that the majority of patients receive a PLT as an infant or very young child. Therefore, they are not able to clearly distinguish between sleep/rest fatigue and normal tiredness, because they have no conscious memories of their state prior to transplantation. This is also confirmed by Taylor et al 31 who suggested that the impact of fatigue was more noticeable to PLT recipients who received a PLT in late childhood or adolescence because they were able to compare feelings of fatigue with their experience prior to becoming ill. These findings also indicate that fatigue or tiredness is an accepted part of the daily lives of PLT recipients. Nevertheless, they must make adjustments to accommodate fatigue, for example, by developing conserving strategies. Therefore, it is not surprising that this domain does not contribute to children's HRQL for all participants in the same way, because substantial differences can be assumed regarding the success of strategies to cope with sleep/rest fatigue. A study on children with cancer-related fatigue suggests that such strategies are influenced by individual temperament, lifestyle, environmental factors, and treatment modalities. 39 Nevertheless, sleep and rest are essential for school functioning. Furthermore, persistent fatigue is known to be one of the major causes of school non-attendance, 40 which might have a negative impact on children's education. 41 Therefore, it is of critical importance to identify patients with high levels of fatigue.
| Implications for future research
A better understanding of the mechanisms underlying fatigue in PLT recipients is urgently needed for the development of appropriate TA B L E 4 Significant predictors of HRQL (PedsQL total score) for child self-report and parent proxy-report intervention strategies to manage it. Regarding the etiology and pathophysiology, several possible factors and biomarkers are discussed in the literature. For example, hypocortisolism is common in liver diseases and is assumed to be a factor leading to fatigue. 16, 42 In a study on patients with chronic fatigue syndrome, hypocortisolism was associated with childhood trauma in these patients and may reflect a biological correlate of vulnerability due to early developmental insults. 43 These findings may also be relevant in the field of PLT, because transplantation is a very stressful and often traumatic event for PLT recipients.
Fatigue is also known to be associated with inflammatory or immune-mediated diseases 44 and might possibly be attributed to immune abnormalities. 16, 45, 46 A recent review of chronic fatigue syndrome suggests that the onset of this syndrome is often linked to virus infections like Epstein-Barr virus, cytomegalovirus, and human herpes viruses. 47 These findings might be important to consider because such infections are common in PLT recipients.
Vitamin D insufficiency and deficiency are also common in PLT recipients 48 and have been associated with fatigue. 49 Several studies on adult populations indicate an improvement of fatigue in healthy individuals 49 and in patients with chronic conditions [50] [51] [52] after vitamin D supplementation.
Immunosuppressive therapy has also been discussed as a possible cause of fatigue in transplant patients. A review of the neurotoxicity of calcineurin inhibitors in pediatric kidney transplant recipients 53 reports that fatigue was one of the most common symptoms and occurred in 38% of the sample. In a recent study, 54 the mental health of 187 young patients with liver diseases was investigated. Fatigue was the most often mentioned factor contributing to participant's mental distress. Higher rates were found in patients under immunosuppressive therapy (after PLT or with autoimmune liver disease) compared to patients without immunosuppression.
| Limitations
Although this study provides valuable results, it also has limitations. The cross-sectional design does not allow causal conclusions to be drawn. Clinical factors such as virus infections, other comorbidities, or complications were not included. We only focus on fatigue in PLT recipients and its impact on HRQL. Therefore, the percentage of explained variance might be lower if other variables such as PLT recipients' cognitive functioning, psychosocial distress, or the emotional well-being of their parents were included in the regression models. Furthermore, a German healthy reference group was not available, and an age-and gender-matched control group is lacking.
| CON CLUS ION
Notwithstanding these limitations, this study provides several implications for the clinical practice. Considering the high prevalence of fatigue and its detrimental impact on HRQL in our sample, we highly recommend to identify patients with fatigue by a standardized assessment during regular follow-up examinations. In contrast to adult patients, PLT recipients rarely complain about these destressing symptoms because the majority of them is not able to clearly distinguish between fatigue and normal tiredness.
The first approach to manage fatigue is a detection and exclusion of treatable causes like anemia, vitamin D deficiency, electrolyte imbalance, or medication side effects (if possible). Currently, no other specific therapies are available because the genesis of fatigue in chronic disease is still poorly understood and very likely to be multifactorial. 16 A study on adult liver transplant recipients indicates that increasing physical fitness and daily physical activity seems promising in reducing fatigue. 19 However, this has to be proven for pediatric patients. To our clinical experience, some of our patients with high levels of fatigue are physically very active.
In conclusion, the results of the present study indicate that an improvement of fatigue symptoms is essential for a better HRQL and of critical importance for cognitive functioning and school achievement. For the development of specific interventions to successfully treat fatigue in this population, knowledge of the underlying mechanisms of fatigue after PLT is a prerequisite. Hopefully, further research will lead to a broader understanding of fatigue in PLT recipients.
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